Skip to main content
. 2021 Apr 19;11:25–40. doi: 10.2147/BLCTT.S245210

Table 4.

Relapse ALL Regimen (Adapted from UKALLR3)

Phase Chemotherapy Agents Schedule
Induction (28 days) Dexamethasone PO Days 1–5, 15–19
Vincristine IV Days 3, 10, 17, 24
Mitoxantrone IV Days 1, 2
Pegaspargase IM/IV Days 3, 18
Methotrexate IT Days 1, 8 (also Days 15, 22 for CNS3)
Consolidation (28 days) Dexamethasone PO Days 1–5
Vincristine IV Day 3
Methotrexate IV Day 8
Pegaspargase IM/IV Day 9
Cyclophosphamide IV Days 15–19
Etoposide IV Days 15–19
Methotrexate IT Day 8
Intensification (28 days) Dexamethasone PO Days 1–5
Vincristine IV Day 3
Cytarabine IV, every 12 hours Days 1, 2, 8, 9
Erwinia ASP IM Days 2, 4, 9, 11, 23
Methotrexate IV Day 22
Methotrexate IT Days 1, 22
Before SCT Fludarabine IV Days 1–5
Cytarabine IV Days 1–5
Liposomal Daunorubicin IV Day 1
Before Maintenancea (weeks 14–29) Dexamethasone PO Days 1–5, 57–61
Vincristine IV Days 3, 59
6-mercaptopurine PO Days 1–42, 57–98
Methotrexate PO Days 10, 17, 31, 38, 67, 74, 88, 95
Etoposide IV Days 42, 49, 99, 106
Cyclophosphamide IV Days 42, 49, 99, 106
Cytarabine IV Days 43–46, 50–53, 100–103, 107–110
Methotrexate IT Days 1, 43, 57, 99
Maintenancea (4-week cycles from weeks 30–104) Dexamethasone PO Days 1–5
Mercaptopurine PO Days 1–28
Methotrexate PO Weekly
Vincristine IV Day 1
Methotrexate IT Day 1

Note: aPhase given to patients who did not go to SCT.

Abbreviations: PO, oral; IV, intravenous; IM, intramuscular; IT, intrathecal; CNS, central nervous system; SCT, stem cell transplant; ASP, asparaginase.